ibuprofen, (r)-isomer has been researched along with reparixin in 1 studies
| Studies (ibuprofen, (r)-isomer) | Trials (ibuprofen, (r)-isomer) | Recent Studies (post-2010) (ibuprofen, (r)-isomer) | Studies (reparixin) | Trials (reparixin) | Recent Studies (post-2010) (reparixin) |
|---|---|---|---|---|---|
| 10 | 0 | 4 | 70 | 4 | 48 |
| Protein | Taxonomy | ibuprofen, (r)-isomer (IC50) | reparixin (IC50) |
|---|---|---|---|
| C-X-C chemokine receptor type 1 | Homo sapiens (human) | 0.0031 | |
| C-X-C chemokine receptor type 2 | Homo sapiens (human) | 0.0354 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allegretti, M; Berdini, V; Bertini, R; Bizzarri, C; Cesta, MC; Colotta, F; Di Bello, N; Di Bitondo, R; Di Cioccio, V; Fantucci, P; Florio, S; Galliera, E; Locati, M; Nano, G; Nicolini, L; Russo, V; Topai, A; Zampella, G | 1 |
1 other study(ies) available for ibuprofen, (r)-isomer and reparixin
| Article | Year |
|---|---|
2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.
Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Movement; Chemokines, CXC; Chemotaxis, Leukocyte; Female; Humans; Ketoprofen; Ligands; Lymphoma; Macrophages, Peritoneal; Mice; Models, Molecular; Mutagenesis, Site-Directed; Propionates; Receptors, Interleukin-8A; Recombinant Proteins; Structure-Activity Relationship | 2005 |